Title: Nedjma Sihem Benaboud: Innovator in Drug Dosing Regimens
Introduction
Nedjma Sihem Benaboud is an accomplished inventor based in Montrouge, France. She has made significant contributions to the field of pharmacology, particularly in developing methods for optimizing drug dosing regimens. Although she currently holds no granted patents, her innovative work is noteworthy.
Latest Patent Applications
Nedjma Sihem Benaboud's latest patent application is titled "Method for Determining an Optimal Drug Dosing Regimen." This invention focuses on a method for determining an optimum drug dosing regimen to treat patients effectively against drug-sensitive pathogenic agents. The method utilizes relevant patient-related data and drug concentration measurements taken at random times in the patient's body. It estimates the drug concentration time-course based on a Bayesian model. The residual concentration (C) and an efficiency pharmacokinetic parameter (PPE) adapted to the specific drug and patient are computed from the estimated concentration. A dosing regimen is then established by comparing the PPE to an efficiency target (CE) for optimal treatment. Additionally, the method considers toxicity constraints by comparing the residual drug concentration (C) to at least a toxic concentration (C). Ultimately, a concentration of the drug is determined (E) based on the results of these comparisons to propose a dose for the optimum dosing regimen.
Conclusion
Nedjma Sihem Benaboud is a promising inventor whose work in drug dosing regimens has the potential to enhance patient care significantly. Her innovative approach to pharmacology reflects her dedication to improving treatment outcomes.